Kala Pharmaceuticals, Inc. Gains 22.8%
Wed, Nov 09, 2022 at 07:52 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) soared at $6.41, a gain of 22.8%. On Wed, Nov 09, 2022, KALA:NASDAQ touched a New 2-Week High of $6.41. The stock appeared on our News Catalysts scanner on Tue, Nov 08, 2022 at 08:49 AM in the 'INVESTOR UPDATE' category. From Wed, Oct 26, 2022, the stock recorded 40.00% Up Days and 27.27% Green Days
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ), 212.75%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Outset Medical Inc. (OM:NASDAQ), 29.9%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 29.6%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Riskified Ltd. Class A (RSKD:NYSE), 24.94%
- Health Catalyst, Inc. (HCAT:NASDAQ), 23.34%
- Quotient Technology Inc. (QUOT:NYSE), 22.81%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 22.8%
- Vivint Smart Home, Inc. (VVNT:NYSE), 20.57%